S. Ehrenforth

2.6k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

S. Ehrenforth is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, S. Ehrenforth has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 13 papers in Internal Medicine and 7 papers in Genetics. Recurrent topics in S. Ehrenforth's work include Blood Coagulation and Thrombosis Mechanisms (22 papers), Hemophilia Treatment and Research (17 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). S. Ehrenforth is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (22 papers), Hemophilia Treatment and Research (17 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). S. Ehrenforth collaborates with scholars based in Germany, Japan and Denmark. S. Ehrenforth's co-authors include I. Scharrer, W. Kreuz, Ulrike Nowak‐Göttl, B. Kornhuber, Markus B. Funk, B. Krackhardt, Tayfun Güngör, R. Linde, Ralf Junker and Hans-Georg Koch and has published in prestigious journals such as The Lancet, Blood and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

S. Ehrenforth

37 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1992 471 citations S. Ehrenforth, W. Kreuz et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Ehrenforth Germany	19	1.5k	459	328	270	169	38	1.8k
Barry Woodhams United Kingdom	22	741 0.5×	319 0.7×	204 0.6×	257 1.0×	237 1.4×	71	1.4k
Hoyu Takahashi Japan	26	962 0.6×	281 0.6×	216 0.7×	239 0.9×	154 0.9×	84	1.6k
Guglielmo Mariani Italy	21	1.5k 1.0×	424 0.9×	343 1.0×	296 1.1×	115 0.7×	55	2.0k
Marie Dreyfus France	24	1.5k 1.0×	420 0.9×	256 0.8×	255 0.9×	65 0.4×	69	2.0k
Mariasanta Napolitano Italy	22	711 0.5×	195 0.4×	337 1.0×	116 0.4×	148 0.9×	117	1.3k
Marietta Kollars Austria	17	690 0.5×	493 1.1×	165 0.5×	340 1.3×	277 1.6×	31	1.3k
A Girolami Italy	20	894 0.6×	319 0.7×	275 0.8×	217 0.8×	76 0.4×	120	1.4k
Eugenia Biguzzi Italy	18	540 0.4×	207 0.5×	120 0.4×	150 0.6×	85 0.5×	50	929
PC Comp United States	14	1.2k 0.8×	301 0.7×	328 1.0×	287 1.1×	35 0.2×	19	1.4k
Graziella Saggiorato Italy	21	459 0.3×	196 0.4×	155 0.5×	101 0.4×	128 0.8×	44	1.0k

Countries citing papers authored by S. Ehrenforth

Since Specialization

Citations

This map shows the geographic impact of S. Ehrenforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ehrenforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ehrenforth more than expected).

Fields of papers citing papers by S. Ehrenforth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ehrenforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ehrenforth. The network helps show where S. Ehrenforth may publish in the future.

Co-authorship network of co-authors of S. Ehrenforth

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ehrenforth. A scholar is included among the top collaborators of S. Ehrenforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ehrenforth. S. Ehrenforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oldenburg, Johannes, Manuel Carção, Steven R. Lentz, et al.. (2018). Once‐weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9‐GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials. Haemophilia. 24(6). 911–920. 13 indexed citations

Meunier, Sandrine, Jayanthi Alamelu, S. Ehrenforth, et al.. (2017). Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A. Thrombosis and Haemostasis. 117(9). 1705–1713. 47 indexed citations

Giangrande, Paul, T. A. Andreeva, Pratima Chowdary, et al.. (2016). Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A. Thrombosis and Haemostasis. 117(2). 252–261. 93 indexed citations

Lentz, Steven R., S. Ehrenforth, Faraizah Abdul Karim, et al.. (2014). Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa. Journal of Thrombosis and Haemostasis. 12(8). 1244–1253. 52 indexed citations

Paula, Erich Vinícius De, Kaan Kavaklı, Johnny Mahlangu, et al.. (2011). Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. Journal of Thrombosis and Haemostasis. 10(1). 81–89. 24 indexed citations

Ehrenforth, S., et al.. (2008). APC-Resistenz und venöse Thrombophilie: Molekulargenetische Prävalenzstudie in der deutschen Bevölkerung. DMW - Deutsche Medizinische Wochenschrift. 124(25/26). 783–787. 4 indexed citations

Ehrenforth, S., László Nemes, Christine Mannhalter, et al.. (2004). Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A. Journal of Thrombosis and Haemostasis. 2(3). 430–436. 18 indexed citations

Veldman, Alex, Maureane Hoffman, & S. Ehrenforth. (2003). New Insights into the Coagulation System and Implications for New Therapeutic Options with Recombinant Factor VIIa. Current Medicinal Chemistry. 10(10). 797–811. 55 indexed citations

Czwalinna, Andreas, Roswith Eisert, C. Wermes, et al.. (2001). Prevalence of a 23bp Insertion in Exon 3 of the Endothelial Cell Protein C Receptor Gene in Venous Thrombophilia. Thrombosis and Haemostasis. 86(12). 1360–1362. 15 indexed citations

10.

Pabinger, Ingrid, László Nemes, C. Rintelen, et al.. (2000). Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. The Hematology Journal. 1(1). 37–41. 53 indexed citations

11.

Ehrenforth, S., Joachim Schenk, & I. Scharrer. (1999). Liver Damage Induced by Coumarin Anticoagulants. Seminars in Thrombosis and Hemostasis. 25(1). 79–83. 27 indexed citations

12.

Nowak‐Göttl, Ulrike, N. Münchow, Michael Paulussen, et al.. (1999). The course of fibrinolytic proteins in children with malignant bone tumours. European Journal of Pediatrics. 158(S3). S151–S153. 10 indexed citations

13.

Ehrenforth, S., R. Junker, Hans Georg Koch, et al.. (1999). Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. European Journal of Pediatrics. 158(S3). S97–S104. 98 indexed citations

14.

Nowak‐Göttl, Ulrike, C. Wermes, Ralf Junker, et al.. (1999). Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors. Blood. 93(5). 1595–1599. 151 indexed citations

15.

Vielhaber, H., S. Ehrenforth, Hans Georg Koch, et al.. (1998). Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. European Journal of Pediatrics. 157(7). 555–560. 72 indexed citations

16.

Kreuz, W., S. Ehrenforth, Markus B. Funk, et al.. (1995). Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow‐up. Haemophilia. 1(1). 24–32. 54 indexed citations

17.

Kreuz, W., Sabine Becker, Inmaculada Martinez‐Saguer, et al.. (1995). Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII. Seminars in Thrombosis and Hemostasis. 21(4). 382–389. 36 indexed citations

18.

Ehrenforth, S., Emel Aygören‐Pürsün, V. Hach-Wunderle, & I. Scharrer. (1994). Prevalence of Elevated Histidine-Rich Glycoprotein in Patients with Thrombophilia - a Study of 695 Patients. Thrombosis and Haemostasis. 71(1). 160–161. 13 indexed citations

19.

Güngör, Tayfun, Markus B. Funk, R. Linde, et al.. (1993). Combined therapy in human immunodeficiency virus-infected children —a 4-year experience. European Journal of Pediatrics. 152(8). 650–654. 2 indexed citations

20.

Ehrenforth, S., W. Kreuz, R. Linde, et al.. (1992). Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. The Lancet. 339(8793). 594–598. 471 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact